Binding affinity maturation without structure determination remains a difficult challenge in the 28 computer-aided protein engineering. Precise binding mode identification is a vital prerequisite for 29 the affinity maturation. However, pure computational methods have been unreliable in practice so 30 far and experimental structural biology techniques are generally too costly. Herein, we show that 31 computational epitope localization followed by the full-atom energy minimization with 32 intermediate experimental validation can yield precisely bound complex model structure, which 33 ultimately enables effective affinity maturation and redesign of binding specificity. As a proof-of-34 concept, we targeted a leucine-rich repeat (LRR) protein binder which specifically binds to the 35 human IgG1 (hIgG1). Based on the computationally predicted binding mode of the LRR protein 36 binder to hIgG1, the binding affinity of the protein binder was significantly increased and its 37 specificity was redesigned toward multiple IgGs from other species. Experimental determination 38 of the complex structure showed that the predicted model closely matched the X-ray crystal 39 structure. Through the benchmark of therapeutically relevant existing LRR protein complexes, we 40 demonstrate that the present approach can be broadly applicable to other proteins which undergo 41 small conformational changes upon binding. 42 43
Introduction 56
Protein-protein interactions are central to all biological processes, including signal transduction, 57 cellular regulation, and immune response (1). Determining the binding mode of such interactions 58 thus provides fundamental insight into the underlying mechanisms for the control and regulation 59 of biological processes. In the development of both therapeutic proteins and vaccines, because the 60 precise identification of the binding mode is particularly important, because the efficacy varies 61 depending on their epitopes (2-4) and the effectiveness of vaccines are affected by their epitopes 62 (5) (6) (7) . Although the experimental determination of the crystal structures has been used as the gold 63 standard for binding mode identification (8), it is extremely labor-intensive and time-consuming. 64 Therefore, considerable effort has been made to develop computational methods as alternatives 65 over the past decades (9, 10). One of the practical applications of the binding mode prediction is 66 an affinity maturation of a protein binder from scratch without structure determination, which has 67 been regarded as one of the "Holy Grails" in the computationally-aided protein engineering (11) . 68
However, computational approaches have been insufficiently reliable in practice so far for 69 predicting the binding mode (12, 13) and the association energies (11) . Last rounds of the Critical 70 Assessment of Predicted Interactions (CAPRI) have also shown that current computational 71 methods are not successful in identifying the actual binding mode which is necessary for affinity 72 maturation of a protein binder from scratch (14) (15) (16) . 73
Leucine-rich repeat (LRR) proteins have a rigid horseshoe-like structural feature and play 74 key roles in many biological processes (17) including the immune system (18-21) and cellular 75 processes (22) (23) (24) . Leucine-rich repeat (LRR) proteins constitute one of the most common protein 76 families found in a wide range of species, and more than 2,000 LRR proteins have been identified 77 (25, 26) . Typical examples include mammalian toll-like receptors (TLR) and the variable 78 lymphocyte receptors (VLR) of jawless vertebrates in innate and adaptive immune systems, 79 respectively (19, 21) . Considering the importance and abundance of LRR proteins in nature, a 80 broadly enabling strategy for the control of LRR binding is of great significance for accelerating 81 the understanding of their functions as well as advancing the potential applicability to other 82 therapeutic protein binders. 83
Herein, we demonstrate computer-driven binding mode prodeiction and affinity maturation 84 of a leucine-rich repeat (LRR) protein binder without structural determination. As a proof of 85 concept, we focued on a LRR protein binder which specifically binds to an immunoglobulin G 86 (IgG) . IgG is a challenging model system to show the redesign of binding affinity and specificity, 87 since it is structurally highly conserved, but diverse in sequence among species. We show that a 88 computationally-guided approach can effectively narrow down where the binding interface is, and 89 the full-atom energy minimization can identify a native-like complex model which closely 90 matched the X-ray crystal structure. Further energy calculations on the predicted model complex 91 enabled the redesign of the binding affinity and specificity of the LRR protein binder. 92
93
Results 94
Binding mode prediction of an LRR protein binder 95
In an effort to exploit the structural and functional features of LRR proteins for biotechnological 96 and medical applications, we previously developed an LRR protein binder, called "repebody (Rb)" 97 (27) . As a proof of concept, in this work, a human IgG1 (hIgG1)-binding repebody (RbF4) (28) 98 was targeted for the binding mode prediction and affinity maturation without the structure 99 determination. There is indirect evidence that RbF4 binds to the constant region of hIgG1 (hFc) 100 (28, 29), but actual epitopes and the binding mode were completely unknown. RbF4 has a typical 101 LRR protein sequence motif, whose structural scaffold consists of three major parts: 1) an N 102 terminal cap (LRRNT), 2) LRR modules (LRRVs), and 3) a C terminal cap (LRRCT) with an 103 additional loop ( Fig. S1) . Unlike the complementary determining regions of antibodies, the target 104 binding sites of a repebody comprise parallel beta strands (LRRVs), which are assumed to remain 105 unchanged upon target-binding. During the development of RbF4, three variable residues on each 106 module of LRRV2-LRRV5 (LRRV4 excluded) were randomized and subject to a phage display 107 selection(28). 108
To predict the binding mode of RbF4-hFc, we first localized the RbF4 epitope on hFc using 109 EpiScope, a computational method that provides optimal sets of disruptive (triplet) mutations 110 against possible docking models (12). For antibody-antigen pairs, on average of three mutation 111 sets are sufficient to cover all of the docking models, and at least one set of mutations is expected 112 to overlap the true epitopes (epitope localization). It should be noted that epitope localization only 113 provides a rough idea of where the protein would bind and does not provide the binding mode. 114
ClusPro webserver (30) was employed to dock the RbF4-hFc pair, as demonstrated in the previous 115 study (12). We used a crystal structure of the unbound form of hFc (PDB code: 3AVE) and a 116 homology model of RbF4 for the docking (Table 1) , assigning attractions at the concave residues 117 of LRRV modules from 2 to 5, as known during the phage display selection. We assumed that the 118 major driving force of RbF4 for target binding should be no different from antibodies or high 119 affinity protein binders (Antibody Mode) (31). The antibody docking mode was enabled to 120 generate target-bound complex structures, yielding 29 models in total (Table 1) . Variants with the 121 triplet mutation sets were then experimentally verified by measuring their binding affinity using 122 isothermal titration calorimetry (ITC). 123
Any mutations are symmetrically present due to the symmetric nature of the Fc domain 124 structure. Considering the symmetry, three mutation sets (thus, six in total) in contact with all of 125 the generated docking models were identified (Var 1, 2, and 3 in Fig. 1A) . Among the three designs 126 (with triple mutations each), Var 3 (H75A, N80K, and H200K) was shown to be approximately 3-127 times more disruptive to RbF4 compared to the wild-type hFc, resulting in a decrease in Kd from 128 128 nM to 427 nM ( Fig. 1B and Fig. S2 ). This result confirms that RbF4 indeed binds to hFc. 129
Although the hFc interface region in contact with RbF4 was roughly identified through the triplet, 130 it is probable that not all of them are involved in the binding. We therefore measured the binding 131 affinities of the single variants. Among the triplet, two single mutations (H75A and N80A) led to 132 meaningful reductions (two-fold decreases) in the binding affinities (194 and 187 nM respectively), 133
whereas the binding affinity of H200K remained similar (or stronger) to that of the wild-type hFc. 134
From the binding tests, it is likely that RbF4 establishes contacts with H75 and N80, but unlikely 135 with H200. There were seven RbF4-hFc docking models in contact with the two residues (H75 136 and N80), but not with H200 or the six other positions in Var 1 and 2 ( Fig. 1C) . 137
We hypothesized that the all-atom force field energy could largely capture the binding free 138 energy landscape, and consequently, the model with the lowest force field energy should be near-139 native if any such models exist. Based on this hypothesis, the seven docking models were ranked 140 in terms of the AMBER99sb force field parameter (32) after full-atom minimization using the 141 Tinker molecular dynamics package (33). The determination of the X-ray crystal structure (PDB 142 ID: 6KA7) confirms that the binding mode of the docking model with the lowest energy ( Fig. 1C  143 and D, blue model) and the crystal structure are extremely similar (fnat: 0.43 and I-RMSD: 2.32 Å, 144 see Fig. 2 ). These results demonstrate that the computational prediction with intermediate 145 experimental validation enabled the binding mode prediction for LRR proteins. The computational 146 method suggests an optimal set of mutations to test based on the docking models. The experimental 147 verification using binding assays then effectively narrows down the plausible computational 148 docking model candidates, and the full-atom minimization assists in the ranking of the filtered 149 docking models, leading to the identification of a native-like docking model. It is noteworthy that 150 the prior epitope localization is an essential step for precise binding mode prediction. A ranking 151 assessment using the force field energy alone may be insufficient for finding a native-like docking 152 model ( Fig. 2B and C) . 153 154
Redesign of binding specificity based on the predicted binding mode 155
Based on the predicted binding mode, we redesigned RbF4 to mitigate its binding specificity. RbF4 156 was identified as highly specific for human IgG1, while showing weak and negligible cross-157 reactivities against mouse IgG1 and rabbit IgG (28, 29). The predicted binding mode reveals that 158 the loop (Fig. S1 ) may be largely responsible for the binding specificity of RbF4 toward hFc ( Fig.  159   1D) . To obtain insight into the specificity, we investigated the Fc sequences of IgGs from three 160 species: human (hFc), mouse (mFc), and rabbit (rFc). Calculation of the inter-molecular atomic 161 distances between RbF4 and hFc based on the predicted binding mode showed that the RbF4 loop 162 forms a tight contact with the positions where hFc, mFc, and rFc share different amino acids from 163 each other ( Fig. 1D) , strongly implying its crucial role in the binding specificity of RbF4. We thus 164 reasoned that the engineering of the loop would lead RbF4 to a cross-species Fc binder. To prove 165 our hypothesis, we truncated and replaced the loop sequence of RbF4 with flexible amino acids: 166 RNSAGSVA starting at 239 was changed into GG. We measured the binding affinities of the 167 resulting loop-truncated RbF4 variant (RbF4-LT) for the IgGs from the three species through ITC 168 assays: hIgG1 (Trastuzumab), mouse IgG1 (mIgG1), and rabbit IgG (rIgG). 169
As shown in our previous work (29), the original RbF4 strongly binds to hIgG1 with a 170 binding affinity of 128.7 nM, and weakly to mIgG1 with an 8-fold weaker affinity than hIgG1 (1 171 µM), whereas it has a negligible binding affinity for rIgG ( Fig. 3 and Fig. S3 ). The loop-truncated 172 variant (RbF4-LT) gained a binding affinity for rIgG (1.2 µM), indicating that the loop is indeed 173 involved in the binding specificity of RbF4 for hIgG1. The binding affinity of the variant for mIgG1 174 was also improved to 775 nM, whereas that for hIgG1 decreased to a similar level to mIgG1 (598 175 nM). It bears noting that the variant was entirely designed based on the predicted binding mode 176 prior to the determination of the X-ray co-crystal structure. The results indicate that the predicted 177 binding mode is sufficiently accurate for further engineering of the binding specificity. 178 179
Improvement of binding affinity based on the model binding complex 180
Our final goal is to improve the binding affinity of the LRR binder through a computer-aided 181 design. As shown in the binding mode prediction, although the full-atom force field energy alone 182 does not discriminate the native complex, it can largely capture the binding energy landscape. 183
Herein, we used the AMBER force-field energy to select mutations that can simultaneously 184 improve the binding affinities of RbF4 against multiple targets. To reduce the search space, FoldX 185 (34) was employed to scan possible mutations in the loop (Fig. S4) . The predicted binding energy 186 at G243 indicates that the inclusion of the loop may not enhance a binding affinity for rIgG. Thus 187 we aimed to design an RbF4 variant which can bind to both hIgG1 and mIgG1 with high binding 188
affinities. The FoldX scan suggests that S241M may substantially enhance the binding affinities 189 for hIgG1 and mIgG1. The mutation was also observed during the phage display affinity maturation 190 for the mIgG1-specific repebody (29). We then fixed S241M and introduced all other amino acids 191
in silico at S244. The AMBER99sb force field energy was used to minimize the variants. The 192 binding energy prediction indicates that S241M with S244R (RbF4-MR) may significantly 193 improves the binding affinities for both IgGs (Fig. S5) . The ITC binding assy results show that 194
RbF4-MR indeed strongly binds to the two IgGs as predicted, and the binding affinity for mIgG1 195 was markedly increased (1 µM to 168.1 nM, Fig. 3) . 196 197
General applicability of the binding mode prediction 198
To assess the general applicability of the binding mode prediction, we tested three known targets whose co-crystal structures are available ( Table 1) (36). We firstly investigated the detailed settings of the protein docking. Docking without the 202 antibody mode option using ClusPro resulted in a larger number of docking models, but the overall 203 accuracy of such docking models proved to be worse than those generated with the option enabled. 204
As demonstrated in RbF4-hFc, only a small number of variants were sufficient to localize the 205 epitopes (two for C5a and EGFR, and four for IL-6). The filtering process resulted in a subset of 206 "filtered" docking models which include native-like binding modes (5 to 12 models; solid circles 207 in Fig. 4) . In order to identify the most native-like docking model, the ClusPro score was initially 208 considered to rank the filtered docking models. However, the ClusPro score was found to be 209 unreliable for ranking ( Fig. S6) . Figure 4 shows that ranking based on the AMBER force field 210 energy successfully discriminates high-quality docking models for IL-6 and EGFR. It bears noting 211 that the prior epitope localization is again critical. Ranking by the force field energy alone is not 212 sufficient to find native-like docking models. For example, in the case of IL-6, there are two 213 docking models with lower energies than the most native-like model, but both of them are not in 214 contact with true epitopes. 215
The C5a case offers another insight into precise binding mode prediction (Fig. 4, bottom row) . 216
While the binding interfaces were mostly correct (15 out of 18 correct interface residues: 83 %), 217 the predicted binding mode was completely inverted (N terminal to C, and vice versa). During the 218 affinity maturation of the C5a-specific Rb, it was observed that some LRRV modules gave rise to 219 a negligible increase in the binding affinity (36), which suggests that only LRRV1 and 2 are 220 responsible for interacting with C5a. We thus hypothesized that the accuracy of structural 221 modeling and an incorporation of the paratope information may also enhance the docking quality. 222
The four possible combinations of hypotheses (incorporation of the phage display information 223 versus no incorporation, and a homology-model target versus a crystal structure target) reveal that 224 the use of a high-quality structure (here the crystal structure) is not sufficient for accurate binding 225 mode prediction (Fig. 5) This study demonstrated critical criteria to be satisfied for accurate binding mode prediction. 232
The full-atom force field energy is a good indicator to discriminate the most native-like docking 233 model, but it alone may not be sufficient if the initial epitope localization process with 234 experimental verification is omitted. As also shown in the previous study with antibodies (12), 235 high-quality antigen structures are not particularly required for epitope localization in Rb-target 236 pairs. However, they become necessary to generate and predict native-like docking modes. Though 237 an Rb has predefined target-binding sites, not all of them are involved in target-binding. The 238 inclusion of paratope information (e.g. phage display selection) was shown to improve the quality 239 of docking models and binding mode prediction. 240 241 Discussion 242
Prediction of accurate protein binding mode is an essential prerequisite for protein binding affinity 243 maturation without structural determination. It can certainly accelerlate our understanding of 244 protein functions, advancing the potential utility of relevant proteins in basic and translational 245 research. We chose LRR proteins for the binding mode prediction since, as a promising therapeutic 246 protein binder, they have an advantageous property in engineering persepctive because they 247 undergo small structural changes upon binding. To our best knowledge, prediction of protein-248 protein binding modes has not been consistently achieved yet. As a proof of concept, we began 249 with the binding mode prediction of the LRR protein binder which targets the constant domain of 250 human IgG1 (hFc). The AMBER force field energy with full-atom minimization after epitope 251 localization enabled the successful selection of the most native-like docking model. The X-ray 252 crystal structure of the LRR protein complex with hFc is indeed extremely close to the predicted 253 binding model with the lowest energy. 254
Unlike epitope localization or binding site identification, which do not particularly require 255 extremely native-like binding modes in the sampling step (12), the inclusion of native-like samples 256 (i.e., docking models) is absolutely necessary for affinity improvement from scratch. In general, 257 the sampling quality of the antibody-antigen docking often depends on the targets; however, in our 258 case, native-like models were nearly always included in the initial samples. It is likely that the 259 rigid nature of LRR domains enables the successful sampling of high-quality docking models. 260 Therefore, we anticipate that this approach may be in principle applicable not only to LRR domains, 261 but also to any other proteins with rigid binding sites. As also proven in the success of interface-262 guided docking methods (37-39), the exact definition of binding interfaces including paratope 263 mutational data from phage display selection is also critical. As repeatedly shown in our study, 264 selection only based on the force-field energy value may be misled to wrong complex binding 265 modes, perhaps due to the inaccuracy of the energy functions (40). The mutagenesis-based 266 verification and filtering were shown to be a compulsory process in order to complement imperfect 267 energy scores. The computational method used in this study, EpiScope (12), provided the optimal 268 choice of mutations. For the binding mode prediction, six sets of in vitro experiments were 269 performed, which were shown to be sufficient to effectively localize the epitope. With the epitope 270 localization, the full-atom minimization enabled ranking of filtered docking models, resulting in 271 identification of a native-like docking model. 272
The success of the binding mode prediction directly leads to the design of binding 273 specificities and affinities. From the predicted model, we were able to identify which region 274 assigns the binding specificity of RbF4 to the IgGs. The simple manipulation of the binding region 275 entirely changed its binding specificity. The force field energy is indicative of the binding energy. 276
Mutations selected based on the energy dramatically improves binding affinities as predicted. 277
However, it bears noting that design only based on the energy may result in wrong predictions. 278
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310
Methods 311
Computational Methods 312
The computational method initially starts with epitope localization. We used EpiScope for 313 localization of the repebody binding sites with the default settings (12): triple mutations per 314 binding patch, and one pareto-optimal curve and two suboptimal ones. The docking models were 315 generated using the ClusPro webserver (30). The webserver provides "Antibody mode" based on 316 statistics between the Ab epitopes and paratopes (31). The non-CDR masking option was disabled, 317 but the binding sites and residues in the convex (Fig. S1A) were masked for attraction and 318 repulsion, respectively. All model structures were minimized using the Tinker molecular dynamics 319 package (33) with the AMBER99sb parameter set (32) and the GB/SA implicit solvent model (41). 320
There are three Rb-target complex structures in the PDB up to date: IL-6 (PDB code 4J4L), 321 EGFR (4UIP), and C5a (5B4P) binders. Unbound forms of target structures were used for docking 322 (Table 1) . There is a missing loop in the structure of IL-6 (1ALU chain A: 52 SSKEALAEN). The 323 loop was filled using MODELLER (42) and all the backbone atoms of the loop were minimized 324 using Tinker as described above. While Rb has a very rigid predefined structure, a single mutation 325 at the 11 th LRRV position (Fig. S1B) to proline significantly changes structural conformations. 326
Two of the Rbs (4J4L and 5B4P) have such proline residues (at LRRV1 and LRRV2 respectively). 327
The two Rbs were modeled using each other as templates. One LRRV unit of the EGFR Rb (4UIP) 328 was omitted. The trimmed Rb structure was reconstructed by splitting the free Rb at LRRV3 and 329 superimposing the LRRV3 on LRRV2 of the complete Rb using PyMol. 330 331
Preparation of Fc Model and Variants 332
The sequence of the human Fc binder repebody (RbF4) was obtained from a previously 333 published study (28). The Rb structure was modeled using MODELLER with a free form (3RFS:A) 334 as a template structure. A free form of the hFc domain (3AVE) was used for docking. A total of 335 29 docking models were generated using ClusPro (Table 1) . 336
Trastuzumab (trade name, Herceptin) Fc sequence available from the literature (wild-type) 337 and all subsequent variants were reverse translated, codon optimized for expression in mammalian 338 cells, and synthesized by Integrated DNA technologies (IDT), Inc. (Redwood City, CA). CMVR 339 VRC01 expression vector (NIH AIDS reagent program, Germantown, MD) harboring the wild-340 type Fc or the Fc variant sequences was transfected into suspension HEK 293 cells using 341 polyethylenimine (PEI) (Polysciences, Warrington, PA). Briefly, 500 µg of the wild-type Fc or Fc 342 variant DNA was combined with 1 ml of PEI and incubated at room temperature for 10 minutes. 343
The mixture was then added to HEK cells in the suspension and incubated in a humidified chamber 344 at 37 °C with 8% CO2 for at least 5 to 6 days. The secreted wild-type Fc or Fc variants were 345 clarified through centrifugation at 8000 rpm at 4 °C for 15 minutes on a Beckman Avanti-J25 346 centrifuge (Brea, CA). The resulting supernatant was filtered through a 0.45 µm filter to remove 347 any residual cell debris and other large particles before loading onto a FPLC column. 348
Affinity purification was conducted on a pre-packed 5 ml Protein A column (for wild-type 349 
Expression and Purification of Repebodies 358
The gene-encoding repebodies were inserted into NdeI and XhoI restriction sites of a 359 pET21a vector (Invitrogen, Carlsbad, CA). Plasmids were cloned into competent E.coli DH5α 360 cells using a heat shock method (at 42 °C for 90 seconds). The recombinant plasmids were 361 transformed into E.coli Origami-B cells (Merck, Kenilworth, NJ) . Single colonies were inoculated 362 into 5 mL of a Luria-Bertani (LB) medium containing 50 µg/mL carbenicillin and grown overnight 363 at 37 °C in a shaking incubator (200 rpm). A total of 250 mL of LB containing 50 µg/mL 364 carbenicillin was inoculated with an OD600 0.05 volume of the overnight-saturated culture and 365 grown at 37 °C with shaking at 200 rpm until the OD600 reached 0.5-0.8. The cells were induced 366 using 0.5 mM IPTG and incubated at 18 °C with shaking at 200 rpm for 16 hours. The cells were 367 harvested through centrifugation at 8000 rpm for 20 mins and suspended in a lysis buffer (50 mM 368 NaH2PO4, 300 mM NaCl, and 10 mM imidazole, at pH 8.0). After cell lysis by sonication, the cell 369 debris was removed through centrifugation at 16,000 rpm for 1 hour at 4 °C. Cell lysates were 370 loaded into a Ni-NTA column (Qiagen, Hilden, Germany) and washed using a wash buffer solution 371 (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, at pH 8.0). The repebodies were eluted using 372 an elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, at pH 8.0), and further 373 purified using gel permeation chromatography (Superdex 75, GE Healthcare). The buffer of the 374 purified repebodies changed into PBS, and the concentrate was developed in an AmiconUltra 375 centrifugal filter (10 kDa cutoff, Millipore). 376
Determination of crystal structure 377
The Fc domain of human IgG (hFc) was purified after digestion of the purchased human 378 IgG (Sigma, St. Louis, MO) with papain, as described elsewhere (43) The diffraction data were collected at 100 K, with crystals flash-frozen in a crystallization buffer 386 containing 30% glycerol. A single-wavelength (1 Å) dataset was collected using a native crystal 387 on beam line 5C (Pohang Accelerator laboratory, Korea). Integration, scaling, and merging of the 388 diffraction data were conducted using the HKL2000 program suite (44). The initial phases were 389 determined through molecular replacement using the Phenix AutoMR program (45) and human Fc 390 of IgG (PDB accession 1H3X) and repebody (PDB accession 3RFJ) as models. Successive rounds 391 of model building using Coot (46), refinement using the Phenix program (47), and phase 392 combination allowed the building of the complete structure (Table S1) in Fig. S2. (C) There are seven docking models in contact with H75A and N80K. The blue docking 519
complex was found to be at the lowest energy. (D) A close look into the model suggests that the 520 repebody loop (Fig. S1 ) may be responsible for the binding specificity of RbF4 repebody to hFc. 521
IgG from the three species are considered (human; mouse, mFc; and rabbit, rFc). The residues that 522 mFc, hFc, and rFc commonly share are colored in cyan, the two common species are in gray, and 523 those not shared in common at all are in black. structure. The predicted binding mode gives insight that the binding specificity of RbF4 comes 535 from the loop (Fig. 1D) . The IgGs from the three species are bound to the loop truncated RbF4 536 (RbF4-LT). Further computational engineering in the loop on the model complex identified 537 mutations (S241M and S244R, RbF4-MR) that could significantly improve the binding affinity 538 for mIgG1 (1 µM to 168.1 nM) while maintaining that for hIgG1 (Table S2 for details). 539 540 541 Figure 4. Binding mode prediction on various targets. Docking models that are in contact with 542 epitope overlapping residues (localized docking models) are in solid circle. The blue circle is the 543 model with the minimum force field energy (AMBER99sb). Wild-type (star) energy levels are 544 depicted as dotted lines. Crystal structures are in yellow and the docking models with the lowest 545 energies are in blue on the right hand side. In the cases of IL-6 (A, B and C) and EGFR (D, E, and 546 F), the filtered models with the lowest energy values are native-like. Binding mode prediction for 547
C5a is presented in G, H and I. As shown in IL-6, some models have lower energy values than the 548 most native-like docking model, indicating that ranking only by the force-field energy is not 549 sufficient for binding mode prediction. 550 551 552 Figure 5. Impacts of high-quality structure and paratope definition. The incorporation of 553 phage display results and the use of high quality structures (here crystal structures) lead to an 554 extremely accurate prediction of the binding mode. LRRV in blue is assigned for attraction, in red 555 for repulsion and green for neutral (A and H) . Results in the right two columns (I-N) are from 556 docking models with precisely assigned paratopes. Docking models that are in contact with epitope 557 overlapping residues (localized docking models) are in solid circle. Models with the minimum 558 force field energy values are in blue circles. Wild-type (star) energy levels are depicted as dotted 559
lines. Crystal structures are in yellow and the docking models with the lowest energies are in blue 560 on the right hand side. 561 562 563
